These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8783335)

  • 1. Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla.
    Testoni PA; Lella F; Bagnolo F; Caporuscio S; Cattani L; Colombo E; Buizza M
    Pancreas; 1996 Jul; 13(1):61-5. PubMed ID: 8783335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
    Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
    Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
    Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
    Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy.
    Testoni PA; Lella F; Bagnolo F; Buizza M; Colombo E
    Ital J Gastroenterol; 1994 Dec; 26(9):431-6. PubMed ID: 7541258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
    Tulassay Z; Döbrönte Z; Prónai L; Zágoni T; Juhász L
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1109-12. PubMed ID: 9845400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Octreotide in the prevention of hyperamylasemia following ERCP (a controlled multicenter study)].
    Döbrönte Z; Juhász L; Tulassay Z
    Orv Hetil; 1996 Oct; 137(42):2309-12. PubMed ID: 8992429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
    Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
    Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
    Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
    Binmoeller KF; Harris AG; Dumas R; Grimaldi C; Delmont JP
    Gut; 1992 Aug; 33(8):1129-33. PubMed ID: 1383099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct spraying of shakuyakukanzoto onto the duodenal papilla: a novel method for preventing pancreatitis following endoscopic retrograde cholangiopancreatography.
    Fujinami H; Kajiura S; Ando T; Mihara H; Hosokawa A; Sugiyama T
    Digestion; 2015; 91(1):42-5. PubMed ID: 25632916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence.
    Wang J; Shen Y; Zhong Z; Wu S; Zheng L
    Med Sci Monit; 2018 Dec; 24():8964-8969. PubMed ID: 30531679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial.
    Testoni PA; Bagnolo F; Andriulli A; Bernasconi G; Crotta S; Lella F; Lomazzi A; Minoli G; Natale C; Prada A; Toti GL; Zambelli A
    Aliment Pharmacol Ther; 2001 Jul; 15(7):965-72. PubMed ID: 11421871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
    Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography.
    Tulassay Z; Papp J
    Gastrointest Endosc; 1991; 37(1):48-50. PubMed ID: 1706282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis.
    Testoni PA; Bagnolo F; Caporuscio S; Lella F
    Am J Gastroenterol; 1999 May; 94(5):1235-41. PubMed ID: 10235200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rendezvous technique versus endoscopic retrograde cholangiopancreatography to treat bile duct stones reduces endoscopic time and pancreatic damage.
    La Greca G; Barbagallo F; Di Blasi M; Di Stefano M; Castello G; Gagliardo S; Latteri S; Russello D
    J Laparoendosc Adv Surg Tech A; 2007 Apr; 17(2):167-71. PubMed ID: 17484642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.